CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds

Open Access

Peer-reviewed

Research Article

About the Authors

Mai O. Kadry

Roles Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Supervision, Writing – review & editing

Affiliation Therapeutic Chemistry Department, National Research Center, Al Bhoouth Street, Cairo, Egypt

Rehab M. Abdel-Megeed

Roles Formal analysis, Methodology

Affiliation Therapeutic Chemistry Department, National Research Center, Al Bhoouth Street, Cairo, Egypt

The authors have declared that no competing interests exist

Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
CRISPR
Is the Subject Area "CRISPR" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Estradiol
Is the Subject Area "Estradiol" applicable to this article?

Thanks for your feedback.
Prostate gland
Is the Subject Area "Prostate gland" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.